IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX), developer of the Powerlink® System for the minimally invasive treatment of abdominal aortic aneurysms (AAA), announces the appointment of Joseph A. DeJohn as Vice President of Sales, effective immediately. Mr. DeJohn brings more than 20 years of sales management experience in the medical device industry, including serving in senior positions in the peripheral vascular device division at C.R. Bard Corporation.